Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About SPCE Interactive Breakdown Better Bets vs. SPCE Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Virgin Galactic (SPCE)

Market Price (10/29/2025): $4.06 | Market Cap: $185.3 Mil
Sector: Industrials | Industry: Aerospace & Defense

Virgin Galactic (SPCE)

Market Price (10/29/2025): $4.06
Market Cap: $185.3 Mil
Sector: Industrials
Industry: Aerospace & Defense

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -26%		 Weak multi-year price returns
2Y Excs Rtn is -149%, 3Y Excs Rtn is -179%		 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -322 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -18968%
1   Expensive valuation multiples
P/SPrice/Sales ratio is 109x
2   Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -84%, Rev Chg QQuarterly Revenue Change % is -90%
3   Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -17179%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -27708%
4   Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 190%
5   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -168%
6   Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 23%
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -26%
1 Weak multi-year price returns
2Y Excs Rtn is -149%, 3Y Excs Rtn is -179%
2 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -322 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -18968%
3 Expensive valuation multiples
P/SPrice/Sales ratio is 109x
4 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -84%, Rev Chg QQuarterly Revenue Change % is -90%
5 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -17179%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -27708%
6 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 190%
7 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -168%
8 Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 23%

Market Valuation & Key Metrics

SPCES&P 500
REVENUE GROWTHPOOR
Rev LTM ($ Bil)0.0
Rev Chg Q-90.4%6.4%
Rev Chg LTM-84.2%5.2%
Rev Chg 3Y Avg35.4%5.3%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)-0.3
CFO LTM ($ Bil)-0.3
Net Inc LTM ($ Bil)-0.3
Op Mgn LTM-18,967.7%18.8%
CFO/Rev LTM-17,179.4%20.4%
Net Inc Mgn-17,828.0%12.7%
VALUATIONVERY HIGH
P/S109.13.3
P/CFO-0.615.7
P/FCF-0.421.0
P/E-0.623.7
STABILITYFAIR
Debt/Equity2.270.21
Cash/Assets0.520.07

SPCE Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 36.4% change in SPCE stock from 4/29/2025 to 10/28/2025 was primarily driven by a 751.4% change in the company's P/S Multiple.

429202510282025Change
Stock Price ($)2.974.0536.36%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)7.041.70-75.87%
P/S Multiple12.79108.86751.36%
Shares Outstanding (Mil)30.2945.64-50.67%
Cumulative Contribution1.35%

LTM = Last Twelve Months as of date shown
The -47.7% change in SPCE stock from 10/28/2024 to 10/28/2025 was primarily driven by a -112.4% change in the company's Shares Outstanding (Mil).

1028202410282025Change
Stock Price ($)7.744.05-47.67%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)10.741.70-84.19%
P/S Multiple15.48108.86603.24%
Shares Outstanding (Mil)21.4845.64-112.44%
Cumulative Contribution-113.83%

LTM = Last Twelve Months as of date shown
The -95.7% change in SPCE stock from 10/29/2022 to 10/28/2025 was primarily driven by a -253.0% change in the company's Shares Outstanding (Mil).

1029202210282025Change
Stock Price ($)93.204.05-95.65%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)3.401.70-50.01%
P/S Multiple354.73108.86-69.31%
Shares Outstanding (Mil)12.9345.64-253.00%
Cumulative Contribution-123.47%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
SPCE Return105%-44%-74%-30%-88%-31%-98%
Peers Return-8%-1%7%7%-4%6%5%
S&P 500 Return16%27%-19%24%23%17%110%

Monthly Win Rates [3]
SPCE Win Rate50%25%33%50%17%33% 
Peers Win Rate18%18%25%18%20%20% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
SPCE Max Drawdown-9%-45%-75%-60%-89%-60% 
Peers Max Drawdown-20%-4%-9%-5%-11%-7% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: BA, LMT, DFSC, FLY, PEW. See SPCE Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/28/2025 (YTD)

How Low Can It Go

Unique KeyEventSPCES&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-97.7%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven4205.1%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-71.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven256.1%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven313 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-38.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven63.3%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven38 days120 days

Compare to BA, LMT, DFSC, FLY, PEW


In The Past

Virgin Galactic's stock fell -97.7% during the 2022 Inflation Shock from a high on 2/11/2021. A -97.7% loss requires a 4205.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Virgin Galactic (SPCE)

Better Bets than Virgin Galactic (SPCE)

 SPCEBetter Performance than SPCE
MetricValueIndustry (Aerospace & Defense)
Rev Chg LTM-84.2%GE (17.7%), RTX (8.8%), BA (2.4%), LMT (2.9%), GD (11.9%)
Rev Chg 3Y Avg35.4%RKLB (58.4%), VSEC (41.3%), VVX (40.8%), RCAT (69.7%), BYRN (40.4%)
Op Mgn LTM-18967.7%GE (20.5%), RTX (10.3%), BA (-12.4%), LMT (8.2%), GD (10.3%)
CFO/Rev LTM-17179.4%GE (17.2%), RTX (9.3%), BA (-8.2%), LMT (8.7%), GD (11.1%)
FCF/Rev LTM-27708.0%GE (14.7%), RTX (5.5%), BA (-11.3%), LMT (6.3%), GD (9.3%)
Total Yield-163.8%GE (2.5%), RTX (4.2%), BA (-6.3%), LMT (5.8%), GD (6.2%)
 SPCEBetter Performance than SPCE
MetricValueAll Other Sectors
Rev Chg LTM-84.2%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg35.4%NVDA (92.0%), MELI (39.8%), SNOW (36.3%), RCL (37.7%), NU (70.1%)
Op Mgn LTM-18967.7%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM-17179.4%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM-27708.0%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), AMZN (2.0%)
Total Yield-163.8%NVDA (1.8%), MSFT (3.1%), AAPL (2.9%), GOOGL (3.9%), AMZN (2.9%)
 Best Bets In Industrials Sector
 SPCEGATX VRSK ADT CPRT NDSN TDG PCTY CSL CSW PAYC
What You Pay           
P/E-0.618.035.411.627.529.240.238.911.929.326.8
P/EBIT-0.68.624.55.525.119.819.529.413.222.619.5
What You Get           
Rev Chg Q-90.4%11.3%7.8%6.8%5.2%12.1%9.3%12.2%-0.1%16.6%10.5%
Rev Chg LTM-84.2%11.7%7.6%6.6%9.7%4.5%12.8%7.0%4.4%12.3%10.2%
Rev Chg 3Y Avg35.4%9.8%10.0%2.6%9.9%3.6%18.2%22.7%5.2%11.3%17.6%
FCF/Rev 3Y Avg-15,031.0%38.6%32.4%24.1%23.7%21.5%20.8%20.5%18.3%18.1%18.1%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 16%, alpha of 4.2%, and sharpe of 0.76

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Virgin Galactic Stock Jumped 22% in a Month, What Now?Return 
2Virgin Galactic (SPCE) Stock: 37% of days in last 3 months had 1% or greater fluctuation  
3Virgin Galactic Market PriceMarket Price 
4Virgin Galactic vs. Boeing: With Return Forecast Of 14%, Boeing Is A Better BetPeer Comparison 
5Virgin Galactic vs. Lockheed Martin: Neither Seems Like A Good BetPeer Comparison 
6Virgin Galactic vs. The E W Scripps: With Return Forecast Of 15%, The E W Scripps Is A Better BetPeer Comparison 
7Virgin Galactic vs. Citi Trends: With Return Forecast Of 16%, Citi Trends Is A Better BetPeer Comparison 
8Virgin Galactic vs. GoPro: Neither Seems Like A Good BetPeer Comparison 
9Virgin Galactic vs. Fate Therapeutics: With Return Forecast Of 85%-85%, Both Seem Like Good BetsPeer Comparison 
10Virgin Galactic vs. Sangamo Therapeutics: With Return Forecast Of 85%, Virgin Galactic Is A Better BetPeer Comparison 
11ARTICLES  
12Are Space Stocks Worth A Look As iPhone Adds Satellite Communications? September 12th, 2022
13This Futuristic Theme Is Holding Up Despite The Market Rout. Should You Buy? May 10th, 2022
14Space Stocks Are Having Another Rough Year. Should You Buy? February 9th, 2022
15Down 13% Last Week, What’s Next For Virgin Galactic Stock October 18th, 2021
16Space Stocks To Watch As SpaceX And Blue Origin See New Milestones October 15th, 2021
Title
0DASHBOARDS
1Are Space Stocks Worth A Look As iPhone Adds Satellite Communications?
2This Futuristic Theme Is Holding Up Despite The Market Rout. Should You Buy?
3Space Stocks Are Having Another Rough Year. Should You Buy?
4Down 13% Last Week, What’s Next For Virgin Galactic Stock
5Space Stocks To Watch As SpaceX And Blue Origin See New Milestones
6ARTICLES
7Virgin Galactic Stock Jumped 22% in a Month, What Now?
8Virgin Galactic (SPCE) Stock: 37% of days in last 3 months had 1% or greater fluctuation
9Virgin Galactic Market Price
10Virgin Galactic vs. Boeing: With Return Forecast Of 14%, Boeing Is A Better Bet
11Virgin Galactic vs. Lockheed Martin: Neither Seems Like A Good Bet
12Virgin Galactic vs. The E W Scripps: With Return Forecast Of 15%, The E W Scripps Is A Better Bet
13Virgin Galactic vs. Citi Trends: With Return Forecast Of 16%, Citi Trends Is A Better Bet
14Virgin Galactic vs. GoPro: Neither Seems Like A Good Bet
15Virgin Galactic vs. Fate Therapeutics: With Return Forecast Of 85%-85%, Both Seem Like Good Bets
16Virgin Galactic vs. Sangamo Therapeutics: With Return Forecast Of 85%, Virgin Galactic Is A Better Bet

Trade Ideas

Select past ideas related to SPCE. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
FCN_9302025_Dip_Buyer_ValueBuy09302025FCNFTI ConsultingDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.2%5.2%-6.2%
ODFL_9122025_Monopoly_xInd_xCD_Getting_Cheaper09122025ODFLOld Dominion Freight LineMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.1%-6.1%-7.3%
EFX_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025EFXEquifaxMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-9.0%-9.0%-9.0%
UHAL_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025UHALU-HaulMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.8%-4.8%-5.6%
BWXT_8312025_Quality_Momentum_RoomToRun_10%08312025BWXTBWX TechnologiesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		28.1%28.1%-1.2%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
FCN_9302025_Dip_Buyer_ValueBuy09302025FCNFTI ConsultingDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.2%5.2%-6.2%
ODFL_9122025_Monopoly_xInd_xCD_Getting_Cheaper09122025ODFLOld Dominion Freight LineMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.1%-6.1%-7.3%
EFX_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025EFXEquifaxMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-9.0%-9.0%-9.0%
UHAL_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025UHALU-HaulMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.8%-4.8%-5.6%
BWXT_8312025_Quality_Momentum_RoomToRun_10%08312025BWXTBWX TechnologiesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		28.1%28.1%-1.2%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences82.5%344.7%
2DYNDyne Therapeutics45.0%3.1%
3RNAAvidity Biosciences42.6%140.5%
4LUMNLumen Technologies40.2%89.3%
5GTXGarrett Motion39.2%96.3%
6CLBCore Laboratories36.8%-4.6%
7VICRVicor36.2%85.5%
8MOFGMidWestOne Financial32.7%32.9%
9WWayfair31.7%140.3%
10GLUEMonte Rosa Therapeutics29.6%79.1%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-67.9%6328.6%
2NTLAIntellia Therapeutics-48.2%19.7%
3ITGRInteger-37.0%-48.7%
4METCRamaco Resources-32.4%179.1%
5UAMYUnited States Antimony-26.2%416.4%
6OGNOrganon-26.2%-54.3%
7USARUSA Rare Earth-24.7%67450.3%
8WRLDWorld Acceptance-23.9%21.5%
9SMPLSimply Good Foods-22.2%-49.3%
10METCBRamaco Resources-20.1%65.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines280.5%159.0%
2INBXInhibrx Biosciences112.0%344.7%
3DYNDyne Therapeutics96.4%3.1%
4VICRVicor85.0%85.5%
5NVTSNavitas Semiconductor78.4%259.4%
6LUMNLumen Technologies70.6%89.3%
7BALYBallys70.4%8.8%
8GLUEMonte Rosa Therapeutics70.0%79.1%
9NUVBNuvation Bio66.8%101.9%
10RNAAvidity Biosciences64.0%140.5%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-53.4%6328.6%
2OGNOrganon-35.7%-54.3%
3VGVenture Global-34.0% 
4ITGRInteger-32.8%-48.7%
5LENZLENZ Therapeutics-31.4%6.7%
6FLYFirefly Aerospace-30.3% 
7SOCSable Offshore-29.7%-43.1%
8BULLWebull-27.4% 
9NAGENiagen Bioscience-26.6% 
10USNAUsana Health Sciences-26.5%-43.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences82.5%344.7%
2DYNDyne Therapeutics45.0%3.1%
3RNAAvidity Biosciences42.6%140.5%
4LUMNLumen Technologies40.2%89.3%
5GTXGarrett Motion39.2%96.3%
6CLBCore Laboratories36.8%-4.6%
7VICRVicor36.2%85.5%
8MOFGMidWestOne Financial32.7%32.9%
9WWayfair31.7%140.3%
10GLUEMonte Rosa Therapeutics29.6%79.1%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-67.9%6328.6%
2NTLAIntellia Therapeutics-48.2%19.7%
3ITGRInteger-37.0%-48.7%
4METCRamaco Resources-32.4%179.1%
5UAMYUnited States Antimony-26.2%416.4%
6OGNOrganon-26.2%-54.3%
7USARUSA Rare Earth-24.7%67450.3%
8WRLDWorld Acceptance-23.9%21.5%
9SMPLSimply Good Foods-22.2%-49.3%
10METCBRamaco Resources-20.1%65.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Virgin Galactic

Financials

SPCEBALMTDFSCFLYPEWMedian
NameVirgin G.Boeing Lockheed.DEFSEC T.Firefly .GrabAGun. 
Mkt Price4.05223.33485.774.2325.774.8315.30
Mkt Cap0.2169.0112.7---112.7
Rev LTM275,32773,3494101-101
Op Inc LTM-322-9,3765,997-9-211--211
FCF LTM-470-8,5444,593-9-199--199
FCF 3Y Avg-480-2,1395,634-11---245
CFO LTM-292-6,1846,361-9-165--165
CFO 3Y Avg-387-2877,386-10---149

Growth & Margins

SPCEBALMTDFSCFLYPEWMedian
NameVirgin G.Boeing Lockheed.DEFSEC T.Firefly .GrabAGun. 
Rev Chg LTM-84.2%2.4%2.9%166.4%--2.6%
Rev Chg 3Y Avg35.4%7.8%4.3%94.3%--21.6%
Rev Chg Q-90.4%34.9%8.8%330.2%--21.8%
QoQ Delta Rev Chg LTM-69.2%8.5%2.1%35.8%--5.3%
Op Mgn LTM-18,967.7%-12.4%8.2%-209.1%-209.3%--209.1%
Op Mgn 3Y Avg-12,824.2%-6.5%11.0%-699.5%---353.0%
QoQ Delta Op Mgn LTM-12,546.8%2.3%0.0%86.7%--1.1%
CFO/Rev LTM-17,179.4%-8.2%8.7%-212.3%-164.1%--164.1%
CFO/Rev 3Y Avg-11,080.8%-0.3%10.5%-716.7%---358.5%
FCF/Rev LTM-27,708.0%-11.3%6.3%-216.3%-197.5%--197.5%
FCF/Rev 3Y Avg-15,031.0%-2.8%8.0%-777.8%---390.3%

Valuation

SPCEBALMTDFSCFLYPEWMedian
NameVirgin G.Boeing Lockheed.DEFSEC T.Firefly .GrabAGun. 
Mkt Cap0.2169.0112.7---112.7
P/S108.92.21.5---2.2
P/EBIT-0.6-21.418.8----0.6
P/E-0.6-15.826.8----0.6
P/CFO-0.6-27.317.7----0.6
Total Yield-163.8%-6.3%5.8%----6.3%
Dividend Yield0.0%0.0%2.1%---0.0%
FCF Yield 3Y Avg-225.2%-1.5%4.8%----1.5%
D/E2.30.30.2---0.3
Net D/E-0.30.20.2---0.2

Returns

SPCEBALMTDFSCFLYPEWMedian
NameVirgin G.Boeing Lockheed.DEFSEC T.Firefly .GrabAGun. 
1M Rtn18.4%0.9%-0.3%21.6%-28.4%-3.4%0.3%
3M Rtn8.3%-1.2%16.5%8.0%--22.1%8.0%
6M Rtn36.4%22.7%3.5%---22.7%
12M Rtn-47.7%48.2%-10.0%----10.0%
3Y Rtn-95.7%55.3%8.6%---8.6%
1M Excs Rtn11.9%-0.6%-4.7%17.4%-33.7%2.7%1.1%
3M Excs Rtn2.1%-9.4%8.6%4.8%--29.5%2.1%
6M Excs Rtn12.4%-1.2%-20.4%----1.2%
12M Excs Rtn-62.0%25.3%-30.1%----30.1%
3Y Excs Rtn-179.1%-25.6%-67.8%----67.8%

Comparison Analyses

Title
0Virgin Galactic vs. Boeing: With Return Forecast Of 14%, Boeing Is A Better Bet
1Virgin Galactic vs. Lockheed Martin: Neither Seems Like A Good Bet
2Virgin Galactic vs. The E W Scripps: With Return Forecast Of 15%, The E W Scripps Is A Better Bet
3Virgin Galactic vs. Citi Trends: With Return Forecast Of 16%, Citi Trends Is A Better Bet
4Virgin Galactic vs. GoPro: Neither Seems Like A Good Bet
5Virgin Galactic vs. Fate Therapeutics: With Return Forecast Of 85%-85%, Both Seem Like Good Bets
6Virgin Galactic vs. Sangamo Therapeutics: With Return Forecast Of 85%, Virgin Galactic Is A Better Bet
7Virgin Galactic vs. Evolution Petroleum: With Return Forecast Of 85%, Virgin Galactic Is A Better Bet
8Virgin Galactic vs. Lifevantage: With Return Forecast Of 85%, Virgin Galactic Is A Better Bet
9Virgin Galactic vs. VBI Vaccines: With Return Forecast Of 85%, Virgin Galactic Is A Better Bet

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/6/20255/15/20252/26/202511/6/20248/7/20245/7/20242/27/202411/9/20238/1/20235/9/20232/28/202311/3/2022
Key Financials Quarterly            
Total Revenue000042322011
Ebitda-60-77-69-67-87-95-97-98-128-153-144-140
Operating Income-70-88-82-82-102-111-110-114-140-163-153-146
Net Income-67-84-76-75-94-102-104-105-134-159-151-146
EPS-1.47-2.38-2.53-2.66-4.36-5.10-5.20-5.57-9.16-11.40-11.00-11.00
Key Financials TTM            
Total Revenue TTM2679118754222
Ebitda TTM-273-300-318-346-377-418-476-523-565-541-476-410
Operating Income TTM-322-354-377-405-437-475-527-571-602-572-500-428
Net Income TTM-303-329-347-374-404-445-502-549-590-566-500-430
Growth Rates Quarterly            
Total Revenue Growth-90.4%-76.8%-84.7%-76.7%125.5%406.4%223.2%125.3%424.1%22.9%516.3%-70.3%
EBITDA Growth31.4%19.0%28.6%31.8%31.8%37.8%32.7%30.0%-22.3%-74.2%-84.8%-208.1%
Operating Income Growth31.3%20.4%25.4%28.5%27.1%32.0%28.3%21.5%-27.2%-78.8%-88.6%-75.2%
Net Income Growth28.3%17.2%26.5%28.7%30.2%36.0%31.1%28.1%-21.4%-71.3%-86.7%-200.9%
Margins Quarterly            
EBITDA Margin-14753.4%-16697.6%-16118.9%-16632.1%-2067.7%-4786.2%-3448.8%-5673.8%-6837.1%-38979.8%-16567.1%-18256.3%
Operating Income Margin-17227.1%-19186.1%-19103.3%-20330.3%-2412.1%-5599.9%-3911.2%-6613.0%-7459.4%-41685.2%-17642.2%-18978.0%
Net Income Margin-16571.4%-18326.9%-17811.9%-18542.3%-2222.2%-5139.1%-3701.8%-6053.5%-7181.4%-40659.4%-17355.6%-18977.1%
Cash & Debt            
Total Cash4694905636517767658749979408349091,001
Total Debt421421420420419418418417417416416415
Net Debt / (Cash)-48-69-143-232-357-347-456-580-523-417-493-586
Cash Flows Quarterly            
FCF from Operations-55-76-81-79-79-113-95-91-125-136-131-96
Cash Flows TTM            
FCF from Operations TTM-292-315-353-367-379-425-448-484-489-450-380-314
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC-9.8%-12.8%-12.3%-12.9%-17.3%-19.3%-20.2%-22.4%-29.7%-37.7%-38.1%-38.8%
Return on Invested Capital (ROIC) TTM            
ROIC TTM-11.3%-12.8%-14.2%-16.0%-18.5%-20.7%-24.2%-27.9%-32.0%-33.0%-31.0%-28.5%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Single Segment72304
Total72304


Price Behavior

SPCE Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.010.741.721.161.441.95
Up Beta1.322.272.801.041.091.49
Down Beta-2.04-0.170.010.590.951.61
Up Capture248%40%269%225%239%503%
Bmk +ve Days13233574144420
Stock +ve Days9193154105321
Down Capture-302%50%72%163%155%111%
Bmk -ve Days8192952107330
Stock -ve Days9202865133413

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity10,443,300
Short Interest: % Change Since 93020256.1%
Average Daily Volume6,201,241
Days-to-Cover Short Interest1.68
Basic Shares Quantity45,641,000
Short % of Basic Shares22.9%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/6/2025-9.5%-19.6%-14.8%
5/15/202543.3%9.9%-8.7%
2/26/2025-0.3%-9.1%-15.4%
11/6/2024-11.8%-0.6%-9.0%
8/7/202414.0%17.8%10.8%
5/7/2024-1.5%25.7%-18.0%
2/27/2024-7.9%-15.8%-23.2%
11/8/202319.2%40.4%49.4%
...
SUMMARY STATS   
# Positive1097
# Negative141517
Median Positive6.6%15.5%22.4%
Median Negative-9.4%-15.8%-18.4%
Max Positive43.3%40.4%95.9%
Max Negative-17.6%-28.3%-53.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025806202510-Q 6/30/2025
3312025515202510-Q 3/31/2025
12312024226202510-K 12/31/2024
93020241106202410-Q 9/30/2024
6302024807202410-Q 6/30/2024
3312024507202410-Q 3/31/2024
12312023227202410-K 12/31/2023
93020231109202310-Q 9/30/2023
6302023801202310-Q 6/30/2023
3312023509202310-Q 3/31/2023
12312022228202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022804202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021228202210-K 12/31/2021
93020211108202110-Q 9/30/2021

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.